Skip to main content


Press Releases

December 12, 2017
Health Canada approves Anthrasil® under Extraordinary Use New Drug Regulations GAITHERSBURG, Md., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has been awarded a contract by the Department of National Defence (DND) valued at approximately $8 milli...


Corporate Headquarters Ribbon Cutting

Lynn R. Kieffer 
TEL 240-631-3391 

Robert Burrows 
TEL 240-631-3280